Ventricular ectopic beats: not so benign

Author:
  • DWDavid J Wilber
    David J Wilber

Abstract
There are substantial gaps in our understanding of this process. There are no epidemiological data defining the prevalence of high-frequency PVCs assessed by 24 h monitoring in the general population; the size of the population at risk for developing cardiomyopathy is unknown. Is the risk determined by absolute PVC frequency alone? PVC frequency is at least modestly correlated to the extent of LV dysfunction and ventricular dilation at the time of initial clinical presentation;7 9–11 the vast majority of patients who demonstrated improved ventricular function following ablation had PVC frequencies >10 000/24 h.7–10 However, both initially reduced LVEF and normalisation of ventricular function postablation are also observed in patients with lower PVC frequencies, though this occurs much less often.8 10 11 In a majority of patients, the onset of frequent PVCs relative to the onset of LV dysfunction is unknown. Discrimination of PVC-mediated cardiomyopathy from ventricular ectopy caused by pre-existing non-ischaemic myocardial scar and fibrosis may be problematic, particularly at lower PVC frequencies. The role of advanced imaging techniques such as gadolinium-enhanced magnetic resonance imaging to detect pre-existing myocardial scar is unknown but worth exploring. Are there any patient-specific factors that interact with PVC frequency to influence the risk of cardiomyopathy? While a right ventricular outflow tract PVC origin is present in a majority of cases, this observation most likely reflects the relative predominance of this site among patients with idiopathic PVCs. Left ventricular sites of origin are not uncommon.9 10 It is possible that genetic factors determining myocardial protein expression in response to PVC-induced stress also play a role.

This publication has 16 references indexed in Scilit: